Literature DB >> 31425792

Changing antimicrobial susceptibility and molecular characterisation of Neisseria gonorrhoeae isolates in Guangdong, China: in a background of rapidly rising epidemic.

Xiaolin Qin1, Yunhu Zhao2, Wei Chen3, Xingzhong Wu1, Sanmei Tang1, Guozhou Li4, Yu Yuqi1, Wenling Cao5, Xiaofeng Liu3, Jinmei Huang1, Jieyi Yang1, Wentao Chen1, Weiming Tang6, Heping Zheng7.   

Abstract

The prevalence of Neisseria gonorrhoeae infections has increased rapidly since 2015 in China. Antimicrobial resistance and molecular mobilisation in N. gonorrhoeae are two important factors driving this increasing prevalence. This study explored changes in antimicrobial susceptibility and molecular characteristics of N. gonorrhoeae collected in Guangdong, China (2013-2017). A total of 704 isolates were collected in two cities in Guangdong. MICs of major antimicrobials were determined. Penicillinase-producing N. gonorrhoeae (PPNG) and tetracycline-resistant N. gonorrhoeae (TRNG) were characterised, and N. gonorrhoeae multiantigen sequence typing (NG-MAST) was performed. High resistance to penicillin (68.2%), tetracycline (85.7%) and ciprofloxacin (98.2%) was observed. Spectinomycin, ceftriaxone and azithromycin appeared effective, with susceptibilities of 100%, 96.4% and 90.7%, respectively. Resistance to penicillin decreased significantly from 78.4% to 73.6% and to azithromycin from 11.9% to 3.7%. Total prevalence of PPNG, TRNG and PPNG/TRNG was 25.4%, 33.1% and 13.4%, respectively. Rates of PPNG decreased significantly from 37.3% to 23.9%, TRNG from 50.0% to 31.3%, and PPNG/TRNG from 23.5% to 11.7%. However, the ratio of African-type PPNG increased significantly (18.4% to 64.1%) compared with decreasing Asian-type PPNG (81.6% to 33.3%), and the ratio of American-type TRNG increased significantly (0% to 13.7%) compared with decreasing Dutch-type TRNG (100% to 86.3%). A total of 271 sequence types (STs) were identified by NG-MAST from 380 isolates collected in 2013, 2014 and 2017, with 145 novel STs. African-type PPNG is increasing and replacing Asian-type, and novel STs have emerged. Gonococcal isolates with new genotypes might contribute to the rising gonorrhoea epidemic in this area.
Copyright © 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Antimicrobial susceptibility; Genotype; NG-MAST; Neisseria gonorrhoeae

Mesh:

Substances:

Year:  2019        PMID: 31425792      PMCID: PMC8179728          DOI: 10.1016/j.ijantimicag.2019.08.015

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  33 in total

1.  Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.

Authors:  M Unemo; D Golparian; G Syversen; D F Vestrheim; H Moi
Journal:  Euro Surveill       Date:  2010-11-25

2.  Australian Gonococcal Surveillance Programme, 1 January to 31 March 2015.

Authors:  Monica M Lahra; Rodney P Enriquez
Journal:  Commun Dis Intell Q Rep       Date:  2015-06-30

Review 3.  Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium.

Authors:  Magnus Unemo; Jorgen S Jensen
Journal:  Nat Rev Urol       Date:  2017-01-10       Impact factor: 14.432

Review 4.  Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Ann N Y Acad Sci       Date:  2011-08       Impact factor: 5.691

5.  Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.

Authors:  Sidharath Dev Thakur; Pamela Araya; Graciela Borthagaray; Patricia Galarza; Alina Llop Hernandez; Daisy Payares; Olga Marina Sanabria Cruz; Maria Elena Trigoso Carvallo; Aura Helena Corredor; Jo-Anne R Dillon
Journal:  Sex Transm Dis       Date:  2017-03       Impact factor: 2.830

6.  Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.

Authors:  Catherine A Ison; Katy Town; Chinelo Obi; Stephanie Chisholm; Gwenda Hughes; David M Livermore; Catherine M Lowndes
Journal:  Lancet Infect Dis       Date:  2013-06-11       Impact factor: 25.071

7.  Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.

Authors:  Robert D Kirkcaldy; Sarah Kidd; Hillard S Weinstock; John R Papp; Gail A Bolan
Journal:  Sex Transm Infect       Date:  2013-12       Impact factor: 3.519

8.  Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013.

Authors:  Fiodar Lebedzeu; Daniel Golparian; Leonid Titov; Nataliya Pankratava; Slavyana Glazkova; Irina Shimanskaya; Natallia Charniakova; Aliaksandr Lukyanau; Marius Domeika; Magnus Unemo
Journal:  BMC Infect Dis       Date:  2015-01-31       Impact factor: 3.090

9.  Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016.

Authors:  Yue-Ping Yin; Yan Han; Xiu-Qin Dai; He-Ping Zheng; Shao-Chun Chen; Bang-Yong Zhu; Gang Yong; Na Zhong; Li-Hua Hu; Wen-Ling Cao; Zhong-Jie Zheng; Feng Wang; Qi Zhi; Xiao-Yu Zhu; Xiang-Sheng Chen
Journal:  PLoS Med       Date:  2018-02-06       Impact factor: 11.069

10.  Consumption of antibiotics in Chinese public general tertiary hospitals (2011-2014): Trends, pattern changes and regional differences.

Authors:  Xiaoyuan Qu; Chang Yin; Xihong Sun; Shusheng Huang; Chaofan Li; Panpan Dong; Xiufang Lu; Zhuo Zhang; Aitian Yin
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

View more
  3 in total

1.  Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019.

Authors:  Xiaomian Lin; Wentao Chen; Qinghui Xie; Yuqi Yu; Yiwen Liao; Zhanjin Feng; Xiaolin Qin; Xingzhong Wu; Sanmei Tang; Heping Zheng
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

2.  Correlates of time to clinical presentation for symptomatic individuals with gonorrhoea in South China: results from a cross-sectional study.

Authors:  Peizhen Zhao; Juan Nie; Huanhuan Cheng; Weiming Tang; Heping Zheng; Bin Yang; Cheng Wang
Journal:  BMJ Open       Date:  2022-03-04       Impact factor: 2.692

3.  In Vitro Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019).

Authors:  Xuechun Li; Wenjing Le; Xiangdi Lou; Caroline A Genco; Peter A Rice; Xiaohong Su
Journal:  Antimicrob Agents Chemother       Date:  2022-05-02       Impact factor: 5.938

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.